Literature DB >> 12431856

Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia.

Katerina Zavitsanou1, Philip B Ward, Xu Feng Huang.   

Abstract

The anterior cingulate cortex is a brain area of potential importance to our understanding of the pathophysiology of schizophrenia. Previous studies suggest abnormalities in the glutamatergic neurotransmission in the anterior cingulate cortex in schizophrenia patients. In the present study we used quantitative autoradiography to investigate the binding of [3H]MK801, [3H]L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and [3H]kainate, which respectively label the N-methyl-D-aspartate (NMDA), AMPA, and kainate receptors of the ionotropic glutamate receptor family, in the left anterior cingulate cortex of 10 schizophrenia patients and 10 controls, matched for age, gender, and postmortem interval.AMPA receptor densities were higher in cortical layer II, whereas NMDA receptor densities were higher in cortical layers II-III in the anterior cingulate cortex of both control and schizophrenia group. In contrast, kainate receptors displayed the highest density in cortical layer V. [3H]AMPA binding was significantly increased by 25% in layer II in the schizophrenia group as compared with the control group. Similarly, a significant 17% increase of [3H]MK801 binding was observed in layers II-III in the schizophrenia group. No statistically significant difference was observed for [3H] kainate binding between the schizophrenia and control groups. These results suggest that ionotropic glutamate receptors are differentially altered in the anterior cingulate region in schizophrenia. The increase in [3H]AMPA and [3H]MK801 binding in the superficial layers suggests a postsynaptic compensation for impaired glutamatergic neurotransmission in the anterior cingulate cortex in schizophrenia. The findings add to a growing body of literature that supports a dysfunction of excitatory activity in the anterior cingulate cortex in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431856     DOI: 10.1016/S0893-133X(02)00347-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  22 in total

1.  Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression.

Authors:  D Koethe; I C Llenos; J R Dulay; C Hoyer; E F Torrey; F M Leweke; S Weis
Journal:  J Neural Transm (Vienna)       Date:  2007-03-19       Impact factor: 3.575

Review 2.  N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.

Authors:  Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

3.  Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.

Authors:  K A Newell; K Zavitsanou; X-F Huang
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

Review 4.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Authors:  Mark D Black
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

5.  Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.

Authors:  S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

6.  Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia.

Authors:  Sandra M Holley; Elizabeth A Wang; Carlos Cepeda; J David Jentsch; Christopher A Ross; Mikhail V Pletnikov; Michael S Levine
Journal:  Schizophr Res       Date:  2013-03-06       Impact factor: 4.939

7.  The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.

Authors:  Zhimin Li; Mona Boules; Katrina Williams; Joanna Peris; Elliott Richelson
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

8.  Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Ken Inada; Beverly H Koller; Sheryl S Moy
Journal:  Brain Res       Date:  2009-10-22       Impact factor: 3.252

9.  Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.

Authors:  Tsung-Ung W Woo; Kevin Shrestha; Christopher Amstrong; Martin M Minns; John P Walsh; Francine M Benes
Journal:  Schizophr Res       Date:  2007-08-14       Impact factor: 4.939

10.  Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.

Authors:  Jana B Drummond; Janusz Tucholski; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.